EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹152 Cr | ₹140 Cr | ₹160 Cr | ₹138 Cr | ₹113 Cr |
What is the latest Total Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹152 Cr |
| Mar2025 | ₹140 Cr |
| Mar2024 | ₹160 Cr |
| Mar2023 | ₹138 Cr |
| Mar2022 | ₹113 Cr |
How is Total Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹152 Cr | 8.77 | |
| Mar2025 | ₹140 Cr | -12.55 | |
| Mar2024 | ₹160 Cr | 16.30 | |
| Mar2023 | ₹138 Cr | 22.23 | |
| Mar2022 | ₹113 Cr | - | |
Compare Total Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹225.1 Cr | -6.7% | -10% | -42.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -6.7% |
-10% |
-42.2% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses